<DOC>
	<DOCNO>NCT02214420</DOCNO>
	<brief_summary>Prior trial show many G1 CHC patient ineligible intolerant PEG-based regimen due prior severe side effect , worsen cytopenia , exacerbation underlie psychiatric disorder , autoimmune disorder . These patient candidate treatment approval SMV SOF early 2014 due combination PEG-regimens . Results COSMOS study suggest patient likely excellent response SMV+SOF without RBV 12 week therapy , 24 week unnecessary . This trial design rapidly enroll complete order confirm hypothesis .</brief_summary>
	<brief_title>SMV + SOF With/Without RBV IFN-II Patients With CHC</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Simeprevir</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>1 . Targeted least 20 % enrollment patient cirrhosis 2 . Adults &gt; /= age 18 year . 3 . Active infection HCV genotype 1 4 . Must health insurance cover therapy SOF+RBV 5 . Female patient childbearing age must negative pregnancy test prior initiate therapy , use least two effective method contraception treatment , undergo monthly pregnancy test . 6 . Patients must either IFNineligible due psychiatric , autoimmune , neurological , cause confirmed appropriate PI ; OR , 7 . IFNintolerant due flulike symptom , psychiatric problem , cytopenia cause deem appropriate PI . 1 . Presence HIV coinfection 2 . Presence HCC 3 . Prior organ transplantation 4 . Any history hepatic decompensation 5 . Patients take following medication : Anticonvulsants Carbamazepine , Oxcarbazepine , Phenobarbital , Phenytoin . Antiinfectiveserythromycin , clarithromycin , telithromycin . Antifungals systemic itraconazole , ketoconazole , posaconazole , fluconazole , voriconazole . Antimycobacterials rifampin , rifabutin rifapentine . Corticosteroids systemic dexamethasone . Propulsives Cisapride . Herbals Milk thistle St. John 's Wart . 6 . Patients expose direct act antiviral agent 7 . Patients severe renal impairment ( estimate Glomerular Filtration Rate ( eGFR ) &lt; 50 mL/min/1.73m2 ) end stage renal disease ( ESRD ) . 8 . Patients platelet count &lt; 50 x109/L , Hemoglobin &lt; 10 g/dL , Neutrophils &lt; 0.5 x109/L . 9 . Women pregnant . 10 . Men whose partner pregnant plan become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>